PubRank
Search
About
Jan W Drijfhout
Author PubWeight™ 85.52
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.
J Clin Invest
2008
3.11
2
Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes.
Proc Natl Acad Sci U S A
2005
2.70
3
Antigen microarray profiling of autoantibodies in rheumatoid arthritis.
Arthritis Rheum
2005
2.30
4
Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Clin Cancer Res
2008
2.06
5
High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.
Cancer Res
2007
1.96
6
Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy.
J Invest Dermatol
2011
1.71
7
Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses.
Proc Natl Acad Sci U S A
2010
1.67
8
Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific.
Blood
2011
1.66
9
Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.
Clin Cancer Res
2008
1.66
10
Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines.
Ann Rheum Dis
2006
1.62
11
Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis.
Ann Rheum Dis
2010
1.59
12
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetes.
Nat Immunol
2012
1.46
13
The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.
Blood
2002
1.41
14
Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment.
Clin Cancer Res
2005
1.30
15
Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
Arthritis Rheum
2010
1.28
16
Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques.
Eur J Immunol
2010
1.27
17
Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer.
Clin Cancer Res
2009
1.27
18
Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.
Int J Cancer
2009
1.26
19
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes.
Nat Immunol
2010
1.24
20
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells.
J Biol Chem
2007
1.23
21
Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro.
J Mol Biol
2007
1.21
22
Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection.
J Virol
2005
1.20
23
LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature.
J Immunol
2010
1.20
24
Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes.
Diabetes
2013
1.16
25
Development of novel LL-37 derived antimicrobial peptides with LPS and LTA neutralizing and antimicrobial activities for therapeutic application.
Peptides
2005
1.16
26
Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants.
J Virol
2005
1.10
27
Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.
Hum Immunol
2003
1.07
28
Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
PLoS Pathog
2010
1.06
29
The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.
J Exp Med
2009
1.05
30
AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz.
Proc Natl Acad Sci U S A
2010
1.04
31
The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle.
J Virol
2010
1.04
32
DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype.
Proc Natl Acad Sci U S A
2006
1.04
33
Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques.
AIDS
2012
1.02
34
Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.
Eur J Immunol
2011
1.01
35
Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant.
Eur J Immunol
2011
0.98
36
ABAP: antibody-based assay for peptidylarginine deiminase activity.
Anal Biochem
2007
0.96
37
Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8β transdimer.
J Immunol
2011
0.95
38
Type 1 diabetes-associated HLA-DQ8 transdimer accommodates a unique peptide repertoire.
J Biol Chem
2011
0.94
39
Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II study.
Int J Cancer
2012
0.94
40
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
Eur J Immunol
2013
0.93
41
Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.
Clin Vaccine Immunol
2010
0.92
42
T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy.
Clin Cancer Res
2011
0.92
43
Validation of a new enzyme-linked immunosorbent assay to detect the triggering proteins and peptides for celiac disease: interlaboratory study.
J AOAC Int
2012
0.89
44
An MVA-based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases.
J Immunother
2008
0.89
45
Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: a phase I/II clinical trial.
Int J Cancer
2012
0.88
46
Anti-citrullinated fibronectin antibodies in rheumatoid arthritis are associated with human leukocyte antigen-DRB1 shared epitope alleles.
Arthritis Res Ther
2012
0.87
47
Fine specificity of monoclonal antibodies against celiac disease-inducing peptides in the gluteome.
Am J Clin Nutr
2008
0.86
48
Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasia.
Int J Cancer
2008
0.85
49
Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and catalase 1 in healthy individuals.
J Infect Dis
2013
0.85
50
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4).
Cancer Immunol Immunother
2009
0.85
51
Evaluation of immunological cross-reactivity between clade A9 high-risk human papillomavirus types on the basis of E6-Specific CD4+ memory T cell responses.
J Infect Dis
2010
0.84
52
Discovery of T cell epitopes implementing HLA-peptidomics into a reverse immunology approach.
J Immunol
2013
0.83
53
Steric hindrance and fast dissociation explain the lack of immunogenicity of the minor histocompatibility HA-1Arg Null allele.
J Immunol
2009
0.83
54
DNA/long peptide vaccination against conserved regions of SIV induces partial protection against SIVmac251 challenge.
AIDS
2013
0.83
55
CD8 T-cell recognition of human 5T4 oncofetal antigen.
Int J Cancer
2006
0.83
56
Expression, purification, and in vitro activity of an arterivirus main proteinase.
Virus Res
2006
0.83
57
ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression.
Arthritis Res Ther
2013
0.82
58
A novel secreted metalloprotease (CD2830) from Clostridium difficile cleaves specific proline sequences in LPXTG cell surface proteins.
Mol Cell Proteomics
2014
0.82
59
Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule.
Immunogenetics
2008
0.82
60
The human lactoferrin-derived peptide hLF1-11 exerts immunomodulatory effects by specific inhibition of myeloperoxidase activity.
J Immunol
2012
0.81
61
Quantifying protein measurands by peptide measurements: where do errors arise?
J Proteome Res
2015
0.81
62
The concentration of anticitrullinated protein antibodies in serum and synovial fluid in relation to total immunoglobulin concentrations.
Ann Rheum Dis
2013
0.81
63
Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule.
Mol Immunol
2009
0.80
64
Immunization with mannosylated peptide induces poor T cell effector functions despite enhanced antigen presentation.
Int Immunol
2007
0.80
65
Magnitude and polarization of P53-specific T-helper immunity in connection to leukocyte infiltration of colorectal tumors.
Int J Cancer
2003
0.80
66
Competition-based cellular peptide binding assay for HLA class I.
Curr Protoc Immunol
2004
0.80
67
High resolution mass spectrometry for rapid characterization of combinatorial peptide libraries.
J Comb Chem
2010
0.80
68
An ensemble of rapidly interconverting orientations in electrostatic protein-peptide complexes characterized by NMR spectroscopy.
Chembiochem
2014
0.80
69
Positively charged amino acids flanking a sumoylation consensus tetramer on the 110kDa tri-snRNP component SART1 enhance sumoylation efficiency.
J Proteomics
2010
0.80
70
CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells.
Cancer Immunol Immunother
2007
0.79
71
Synthesis of 2-alkoxy-8-hydroxyadenylpeptides: towards synthetic epitope-based vaccines.
Bioorg Med Chem Lett
2006
0.79
72
Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
Aging Cell
2013
0.78
73
Development of a nose cream containing the synthetic antimicrobial peptide P60.4Ac for eradication of methicillin-resistant Staphylococcus aureus carriage.
J Pharm Sci
2013
0.78
74
Native thrombocidin-1 and unfolded thrombocidin-1 exert antimicrobial activity via distinct structural elements.
J Biol Chem
2011
0.77
75
Aminopeptidase-resistant peptides are targeted to lysosomes and subsequently degraded.
Traffic
2011
0.77
76
New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides.
Nucl Med Biol
2004
0.77
77
Solution structure of the second PDZ domain of the neuronal adaptor X11alpha and its interaction with the C-terminal peptide of the human copper chaperone for superoxide dismutase.
J Biomol NMR
2005
0.77
78
Linker length dependent binding of a focal adhesion kinase derived peptide to the Src SH3-SH2 domains.
FEBS Lett
2011
0.76
79
Synthesis of modified and hybrid protein derived biopolymers.
Adv Exp Med Biol
2009
0.75